Daniel Drachman - Recent Papers

Miagkov, A., J. Turchan, A. Nath, D.B. Drachman. (2004) Gene transfer of baculoviral p35 by adenoviral vector protects human cerebral neurons from apoptosis.DNA and Cell Biol.23 :496-501.  [PDF]

Zhou, L., J. McConville, V. Chaudhry, R.N. Adams, R.L. Skolasky, A. Vincent, D.B. Drachman (2004) Clinical comparison of MuSK antibody positive and negative myasthenic patients. Muscle & Nerve 30:55-60.  [PDF]

Drachman, D.B. MuSK Antibodies in Myasthenia Gravis: An Uncertain Pathogenic Role. (2004) Journal Watch Neurology 6 (10) :79

Drachman, DB and RA Brodsky (2005) High-dose Therapy for Autoimmune Neurologic Diseases. Current Opinions in Oncology 17:83-88.  [PDF]

Williams, MA, J. Turchan, Y. Lu, A. Nath, and D.B. Drachman (2005) Protection of Human Cerebral Neurons from Neurodegenerative Insults by Gene Delivery of Soluble Tumor Necrosis Factor p75 Receptor. Exp. Brain Research 165:383-91

Schmidt, E.P., D.B. Drachman, C.M. Wiener, L. Clawson, R. Kimball, N. Lechtzin. (2006). Pulmonary Predictors of Survival in ALS: Use in Clinical Trial Design. Muscle & Nerve 33:127 - 132 Muscle Nerve. 2006 Jan;33(1):127-32.  [PDF]

Cudkowicz, ME, JH Shefner, DA Schoenfeld, H Zhang, KI Andreasson, JD Rothstein, DB Drachman, and the Northeast ALS Consortium (2006) Trial of Celecoxib in Amyotrophic Lateral Sclerosis Ann. Neurol. 60:22-31 [PDF]

Kerr, DA, Calabresi PA, Krishnan C, Martin R, Drachman DB, Richert ND, Brodsky RA (2006) High-dose cyclophosphamide in the treatment of aggressive multiple sclerosis.  Neurology 66 Suppl 2. A30  [PDF]

Lu Y,  Adams RN, Sun W, Lee H, Dobromilskaya I, Drachman DB (2006) Targeting of viral vectors to motor neurons by botulinum toxin binding domain to treat ALS. Molecular Therapy 13 Suppl1. S347.  [PDF]